<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01273792</url>
  </required_header>
  <id_info>
    <org_study_id>Biomarkers Susac Syndrome</org_study_id>
    <nct_id>NCT01273792</nct_id>
  </id_info>
  <brief_title>Investigation of Biomarkers in Susac Syndrome</brief_title>
  <official_title>Investigation of Relevant Biomarkers in Patients With Susac Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Susac Syndrome is a rare disease and the establishment of the diagnosis is often difficult.
      The aim of this investigation is to identify relevant biomarkers and to elucidate the
      pathogenesis of Susac syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Susac Syndrome is a rare disease characterized by encephalopathy, branch retinal artery
      occlusion and sensorineural deafness. The pathogenesis is not yet clear, an autoimmune
      endotheliopathy is discussed. Because of the variable and often incomplete clinical
      presentation, the establishment of the diagnosis is often delayed or even completely missed.

      The aim of this study is to identify biomarkers that facilitate the reliable and prompt
      establishment of the diagnosis. Patients with a definite diagnosis of Susac syndrome and
      healthy subjects as controls are investigated.

      Furthermore, the correlation of serological markers with structural retinal and cerebral
      changes will contribute to clarification of the pathogenesis of Susac syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>disease specific patterns of pathology on cranial MRI</measure>
    <description>one-time cranial MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>disease specific patterns of pathology in optical coherence tomography</measure>
    <description>one time optical coherence tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serological biomarkers</measure>
    <time_frame>not defined, cross-sectional analysis</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Susac Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with Susac syndrome</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Matched healthy controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples (serum, Blood cells)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with Susac syndrome (male/female; healthy control subjects
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult male and female patients with definite Susac syndrome or matching healthy
             control subjects

          -  ability to provide informed consent

        Exclusion Criteria:

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan M Dörr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NeuroCure Clinical Research Center, Charité Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan M Dörr, MD</last_name>
    <phone>+49 30 450</phone>
    <phone_ext>660162</phone_ext>
    <email>jan-markus.doerr@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan M Dörr, MD</last_name>
      <phone>+49 30 450</phone>
      <phone_ext>660162</phone_ext>
      <email>jan-markus.doerr@charite.de</email>
    </contact>
    <investigator>
      <last_name>Jan M Dörr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Dörr J, Radbruch H, Bock M, Wuerfel J, Brüggemann A, Wandinger KP, Zeise D, Pfueller CF, Zipp F, Paul F. Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. Nat Rev Neurol. 2009 Dec;5(12):683-8. doi: 10.1038/nrneurol.2009.176.</citation>
    <PMID>19953118</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2011</study_first_submitted>
  <study_first_submitted_qc>January 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2011</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Jan-Markus Dörr</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Susac Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

